CeBIL NNF Collaborative Research Programme Publications

The list covers all publications from 2018 - 2020:

2020

Aboy M, Crespo C, Liddell K, Davey N, Liddicoat J, Minssen T. (2020). One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections?. Nature biotechnology, 38(3), pp. 279-283. doi: 10.1038/s41587-020-0440-4

Belay D, Jensen J. (2020). ‘The scarlet letters’: Information disclosure and self-regulation: Evidence from antibiotic use in Denmark. Journal of Environmental Economics and Management, doi: 10.1016/j.jeem.2020.102385

Belay D, Abate T, Jensen J. (2020). A Montero Auction Mechanism to Regulate Antimicrobial Consumption in Agriculture. American Journal of Agricultural Economics, (5), doi: 10.1002/ajae.12079

Bhaskar S, Tan J, Bogers MLAM, Minssen T, Badaruddin H, Israeli-Korn S, ... Chesbrough H. (2020). At the Epicenter of COVID-19-the Tragic Failure of the Global Supply Chain for Medical Supplies. Frontiers in public health, 8, pp. 562882. doi: 10.3389/fpubh.2020.562882

Boris Babic, I. Glenn Cohen, Theodoros Evgeniou, Sara Gerke. (2020). When Machine Learning Goes Off the Rails. HARVARD BUSINESS REVIEW,

Bostyn S. (2020). Plant Variety Rights Protection and Essentially Derived Varieties: A Fresh Proposal to Untie the Gordian Knot. GRUR International, (8), doi: 10.1093/grurint/ikaa094

Bostyn S. (2020). Personalized Medicine, Intellectual Property Rights and Human Rights. In Torremans P. (Ed.), Intellectual Property and Human Rights  (pp. 907-986). Kluwer Law International.

Bostyn S. (2020). Access to Therapeutics and Vaccines in Times of Health Pandemics: How Exclusivity Rights Can Affect Such Access and What We Can Do About It. Intellectual Property Quarterly, pp. 227-270.

Bradford L, Aboy M, Liddell K. (2020). COVID-19 Contact Tracing Apps: A Stress Test for Privacy, the GDPR and Data Protection Regimes. Journal of Law and the Biosciences, lsaa034, pp. 1-20.

Bradford L, Aboy M, Liddell K. (2020). International transfers of health data between the EU and USA: a sector-specific approach for the USA to ensure an ‘adequate’ level of protection. Journal of Law and the Biosciences, doi: 10.1093/jlb/lsaa055

Celedonia K, Valenti M, Corrales Compagnucci M, Lowery Wilson M. (2020). Community-based health care providers as research participant recruitment gatekeepers: ethical and legal issues in a real-world case example. Research Ethics, doi: 10.1177/1747016120980560

Cohen I, Adashi E, Gerke S, Palacios-González C, Ravitsky V. (2020). The Regulation of Mitochondrial Replacement Techniques Around the World. Annual Review of Genomics and Human Genetics, (1), doi: 10.1146/annurev-genom-111119-101815

Cohen I, Evgeniou T, Gerke S, Minssen T. (2020). The European artificial intelligence strategy: implications and challenges for digital health. The Lancet Digital Health, (7), doi: 10.1016/S2589-7500(20)30112-6

Cohen I. (2020). Informed Consent and Medical Artificial Intelligence: What to Tell the Patient?. SSRN Electronic Journal, doi: 10.2139/ssrn.3529576

Cohen IG, Gerke S, Kramer DB. (2020). Ethical and Legal Implications of Remote Monitoring of Medical Devices. The Milbank quarterly, 98(4), pp. 1257-1289. doi: 10.1111/1468-0009.12481

Corrales Compagnucci M, Minssen T, Seitz C, Aboy M. (2020). Lost on the High Seas without a Safe Harbor or a Shield? Navigating Cross-Border Transfers in the Pharmaceutical Sector After Schrems II Invalidation of the EU-US Privacy Shield. European Pharmaceutical Law Review, (3), doi: 10.21552/eplr/2020/3/5

Darrow J, Najafzadeh M, Stefanini K, Kesselheim A. (2020). Regulatory approval characteristics of antimicrobial versus non-antimicrobial products, 1984–2018: an evaluation of Food and Drug Administration flexibilities. The Lancet Infectious Diseases, (7), doi: 10.1016/S1473-3099(20)30197-3

Darrow JJ, Kesselheim AS. (2020). Incentivizing Antibiotic Development: Why Isn't the Generating Antibiotic Incentives Now (GAIN) Act Working?. Open forum infectious diseases, 7(1), pp. ofaa001. doi: 10.1093/ofid/ofaa001

Deb C, Moneer O, Price WN. (2020). Covid-19, single-sourced diagnostic tests, and innovation policy. Journal of law and the biosciences, 7(1), pp. lsaa053. doi: 10.1093/jlb/lsaa053

Druedahl LC, Almarsdóttir AB, Kälvemark Sporrong S, De Bruin ML, Hoogland H, Minssen T, ... Sarpatwari A. (2020). A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways. Nature biotechnology, 38(11), pp. 1253-1256. doi: 10.1038/s41587-020-0717-7

Druedahl LC, Lebret A, Minssen T. (2020). ELSI Implications of Prioritizing Biological Therapies in Times of COVID-19. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics, 48(3), pp. 579-582. doi: 10.1177/1073110520958884

Gerke S, Babic B, Evgeniou T, Cohen IG. (2020). The need for a system view to regulate artificial intelligence/machine learning-based software as medical device. NPJ digital medicine, 3, pp. 53. doi: 10.1038/s41746-020-0262-2

Gerke S, Yeung S, Cohen IG. (2020). Ethical and Legal Aspects of Ambient Intelligence in Hospitals. JAMA, 323(7), pp. 601-602. doi: 10.1001/jama.2019.21699

Gerke S, Shachar C, Chai PR, Cohen IG. (2020). Regulatory, safety, and privacy concerns of home monitoring technologies during COVID-19. Nature medicine, 26(8), pp. 1176-1182. doi: 10.1038/s41591-020-0994-1

Gerke S, Minssen T & Cohen G. (2020). Ethical and Legal Challenges of Artificial Intelligence-Driven Health Care. In Bohr A, Memarzadeh K. (Ed.), Artificial Intelligence in Healthcare  (pp. 295-336). Academic Press.

Gerke S, Stern AD, Minssen T. (2020). Germany's digital health reforms in the COVID-19 era: lessons and opportunities for other countries. NPJ digital medicine, 3, pp. 94. doi: 10.1038/s41746-020-0306-7

Golbus J, Price W, Nallamothu B. (2020). Privacy Gaps for Digital Cardiology Data Big Problems With Big Data. Circulation, (8), doi: 10.1161/circulationaha.119.044966

Gunnarsdóttir HD, Sinha MS, Gerke S, Minssen T. (2020). Applying the proportionality principle to COVID-19 antibody testing. Journal of law and the biosciences, 7(1), pp. lsaa058. doi: 10.1093/jlb/lsaa058

Joly Y, Dalpé G, Dupras C, Bévière-Boyer B, de Paor A, Dove ES, ... Bombard Y. (2020). Establishing the International Genetic Discrimination Observatory. Nature genetics, 52(5), pp. 466-468. doi: 10.1038/s41588-020-0606-5

Liddell K, Martin S, Palmer S. (2020). Allocating Medical Resources in the Time of Covid-19 - Letter to the Editor. The New England Journal of Medicine,

Liddell K, Skopek JM, Palmer S, Martin S, Anderson J, Sagar A. (2020). Deciding who gets the ventilator: Will some lives be lost unlawfully?. Journal of Medical Ethics Blog.

Liddell K, Skopek JM, Palmer S, Martin S, Anderson J, Sagar A. (2020). Who gets the ventilator? Important legal rights in a pandemic. Journal of medical ethics, 46(7), pp. 421-426. doi: 10.1136/medethics-2020-106332

Liddicoat J, Wested J. (2020). The right recipe for the repurposing omelette. Life Sciences Intellectual Property Review.

Minssen T., Rajam N, & Bogers M. (2020). Clinical trial data transparency and GDPR compliance: Implications for data sharing and open innovation. Science and Public Policy, doi: 10.1093/scipol/scaa014

Minssen T, Outterson K, Rogers Van Katwyk S, Batista PHD, Chandler CIR, Ciabuschi F, ... Hoffman SJ. (2020). Social, cultural and economic aspects of antimicrobial resistance. Bulletin of the World Health Organization, 98(12), pp. 823-823A. doi: 10.2471/blt.20.275875

Minssen T, Mimler M, Mak V. (2020). When Does Stand-Alone Software Qualify as a Medical Device in the European Union?-The Cjeu's Decision in Snitem and What it Implies for the Next Generation of Medical Devices. Medical law review, 28(3), pp. 615-624. doi: 10.1093/medlaw/fwaa012

Minssen T, Nordberg A. (2020). Rules and Tools in the Battle Against Superbugs—A Call for Integrated Strategies and Enhanced International Collaboration to Promote Antimicrobial Drug Development. Infectious Diseases in the New Millennium - Legal and Ethical Challenges  (pp. 111-136). Springer International Publishing.

Minssen T, Seitz C, Aboy M, Corrales Compagnucci M. (2020). The EU-US Privacy Shield Regime for Cross-Border Transfers of Personal Data under the GDPR. European Pharmaceutical Law Review, (1), doi: 10.21552/eplr/2020/1/6

Minssen T, Gerke S, Aboy M, Price N, Cohen G. (2020). Regulatory responses to medical machine learning. Journal of Law and the Biosciences, lsaa002, pp. 1-18.

Minssen, Timo, Goldschmieding, Tue ; Sandfeld Jakobsen, Søren. (2020). Denmark. AI, BIG DATA & MACHINE LEARNING – 2020, 2nd EDITION  (pp. 113-128). Global Legal Insights (GLI).

Price WN, Rai AK, Minssen T. (2020). Knowledge transfer for large-scale vaccine manufacturing. Science (New York, N.Y.), 369(6506), pp. 912-914. doi: 10.1126/science.abc9588

Raunig BL, Kesselheim AS, Darrow JJ. (2020). Drug Shortages and the Defense Production Act. American journal of public health, 110(10), pp. 1504-1505. doi: 10.2105/AJPH.2020.305862

Rome BN, Kesselheim AS. (2020). Transferrable Market Exclusivity Extensions to Promote Antibiotic Development: An Economic Analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71(7), pp. 1671-1675. doi: 10.1093/cid/ciz1039

Schovsbo J, Minssen T, Riis T. (2020). An appraisal of the EU Directive on Trade Secrets. The Harmonization and Protection of Trade Secrets in the EU (pp. 1-6). Edward Elgar Publishing.

Schovsbo Jens, Minssen Timo, Riis Thomas. (2020). The Harmonization and Protection of Trade Secrets in the EU: An Appraisal of the EU Directive. United Kingdom: Edward Elgar Publishing Ltd.

Shachar C, Engel J, Elwyn G. (2020). Implications for Telehealth in a Postpandemic Future Regulatory and Privacy Issues. JAMA, (23), doi: 10.1001/jama.2020.7943

Shachar C, Gerke S, Adashi EY. (2020). AI Surveillance during Pandemics: Ethical Implementation Imperatives. The Hastings Center report, 50(3), pp. 18-21. doi: 10.1002/hast.1125

Sherkow J, Minssen T. (2020). AIRR data under the EU Trade Secrets Directive: aligning scientific practices with commercial realities. The Harmonization and Protection of Trade Secrets in the EU (pp. 237-266). Edward Elgar Publishing.

Sinha MS, Powers JH III, Kesselheim AS. (2020). The Wrong Cure: Financial Incentives for Unimpressive New Antibiotics. Journal of Infectious Diseases,

Wiens J, Price WN, Sjoding MW. (2020). Diagnosing bias in data-driven algorithms for healthcare. Nature medicine, 26(1), pp. 25-26. doi: 10.1038/s41591-019-0726-6

2018-19

Aboy M, Liddell K, Crespo C, Cohen I, Liddicoat J, Gerke S, ... Minssen T. (2019). How does emerging patent case law in the US and Europe affect precision medicine?. Nature Biotechnology, (10), doi: 10.1038/s41587-019-0265-1

Aboy M, Crespo C, Liddell K, Minssen T, Liddicoat J. (2019). Mayo's impact on patent applications related to biotechnology, diagnostics and personalized medicine. Nature biotechnology, 37(5), pp. 513-518. doi: 10.1038/s41587-019-0111-5

Babic B, Gerke S, Evgeniou T, Cohen IG. (2019). Algorithms on regulatory lockdown in medicine. Science (New York, N.Y.), 366(6470), pp. 1202-1204. doi: 10.1126/science.aay9547

Beukel K. (2018). How patent experts create patent breadth. International Journal of Intellectual Property Rights,

Bostyn S, De Jong T, Poort J, Radauer A. (2018). "Effects of Supplementary Protection Mechanisms for Pharmaceutical Products", Technopolis Group, Report commissioned by the Netherlands Ministries of Health and Economic Affairs and Climate,.

Cohen IG, Mello MM. (2018). HIPAA and Protecting Health Information in the 21st Century. JAMA, 320(3), pp. 231-232. doi: 10.1001/jama.2018.5630

Cohen IG, Mello MM. (2019). Big Data, Big Tech, and Protecting Patient Privacy. JAMA, doi: 10.1001/jama.2019.11365

Corrales Compagnucci M, Forgó N, Kono T, Teramoto S, Vermeulen E. (Ed.), (2019). Legal Tech and the New Sharing Economy. Singapore: Springer Nature.

Corrales Compagnucci M. (2019). Big Data, Databases and "Ownership" Rights in the Cloud. Singapore: Springer Nature.

Corrales Compagnucci M., Meszaros J, Minssen T, Arasilango A, Ous T, Rajarajan M. (2019). Homomorphic Encryption: the ‘Holy Grail’ for Big Data Analytics & Legal Compliance in the Pharmaceutical and Healthcare Sector?. European Pharmaceutical Law Review, 3(4), pp. 144-155.

Darrow JJ, Sinha MS, Kesselheim AS. (2018). When markets fail: patents and infectious disease products. Food & Drug Law J, Volume 73(3),

de Miguel Beriain I, Minssen T, Chortara T, Duardo Sánchez A, Feeney O, Felzmann H, ... Herrmann J R. (2019). An EU comparative analysis of the regulation of clinical trials supervisory bodies in the aftermath of Regulation 536/2014. European Public Law,

Druedahl Louise C., De Bruin Marie L., Hoogland Hans, Minssen Timo, van de Weert Marco, Sporrong Sofia Kalvemark, ... Almarsdottir Anna Birna. (2019). MEDICINES AUTHORITY REGULATOR AND INDUSTRY PERCEPTIONS OF BIOSIMILAR INTERCHANGEABILITY.

Gerke S, Minssen T, Yu H, Cohen I. (2019). Ethical and legal issues of ingestible electronic sensors. Nature Electronics, (8), doi: 10.1038/s41928-019-0290-6

Gerke S, Kramer DB, Cohen IG. (2019). Ethical and Legal Challenges of Artificial Intelligence in Cardiology. AIMed Magazine, 2(2), pp. 12–17.

Hey SP, Kesselheim AS, Patel P, Mehrotra P, Powers JH. (2019). US Food and Drug Administration Recommendations on the Use of Surrogate Measures as End Points in New Anti-infective Drug Approvals. JAMA internal medicine, doi: 10.1001/jamainternmed.2019.5451

Holgersson M, Granstrand O, Bogers M. (2018). The evolution of intellectual property strategy in innovation ecosystems: Uncovering complementary and substitute appropriability regimes. Long Range Planning, (2), doi: 10.1016/j.lrp.2017.08.007

Holman C, Minssen T, Solovy E. (2018). Patentability Standards for Follow-On Pharmaceutical Innovation. Biotechnology Law Report, (3), doi: 10.1089/blr.2018.29073.cmh

Holman C, Minssen T, Solovy E. (2018). Patentability Standards for Follow-On Pharmaceutical Innovation. Biotechnology Law Report, (3), doi: 10.1089/blr.2018.29073.cmh

Janos Meszaros, Ho C-S, Corrales Compagnucci M. (2019). Nudging Consent & the New Opt-Out System to the Processing of Health Data in England. In Corrales Compagnucci M, Forgó N, Kono T, Teramoto S, Vermeulen E. (Ed.), Legal Tech and the New Sharing Economy  (pp. 61-82). Singapore: Springer Nature.

Jensen Jørgen D., Belay Dagim. (2018). Production- and Sector-Economical Consequences of Reducing Antibiotics' Usage in the Danish Pig Farming (title translated from Danish). Danish Ministry of Environment and Food.

Jensen, Jørgen Dejgård, Belay, Dagim Gashawtena. (2019). Produktions- og sektorøkonomiske konsekvenser af at reducere antibiotikaforbruget i dansk svineproduktion. IFRO.

Kianzad B, Minssen T. (2018). How Much is Too Much? Defining the Metes and Bounds of Excessive Pricing in the Pharmaceutical Sector. European Pharmaceutical Law Review, (3), doi: 10.21552/eplr/2018/3/5

Klinge UC, Lindgreen N, Minssen T, Valentin A, Brinck-Jensen J, Dokkedahl N, ... Triton Frost T. (2019). AIPPI Report for Denmark on Plausibility in Patent Law: AIPPI 2019 - 2019 Study Questions - Plausibility.

Klugman CM, Dunn LB, Schwartz J, Cohen IG. (2018). Response to Open Peer Commentaries on "The Ethics of Smart Pills and Self-Acting Devices: Autonomy, Truth-Telling, and Trust at the Dawn of Digital Medicine". The American journal of bioethics : AJOB, 18(10), pp. W4-W7. doi: 10.1080/15265161.2018.1514427

Klugman CM, Dunn LB, Schwartz J, Cohen IG. (2018). The Ethics of Smart Pills and Self-Acting Devices: Autonomy, Truth-Telling, and Trust at the Dawn of Digital Medicine. The American journal of bioethics : AJOB, 18(9), pp. 38-47. doi: 10.1080/15265161.2018.1498933

Kongsholm NCH, Christensen ST, Hermann JR, Larsen LA, Minssen T, Pedersen LB, ... Schovsbo J. (2018). Challenges for the Sustainability of University-Run Biobanks. Biopreservation and biobanking, 16(4), pp. 312-321. doi: 10.1089/bio.2018.0054

Liddell K, Liddicoat, J & Jordan M. (2019). IP policies for large bioresources: the fiction, fantasy, and future of openness. Global Genes, Local Concerns  (pp. 242-263). Edward Elgar Publishing.

Liddicoat J, Liddell K, McCarthy AH, Hogarth S, Aboy M, Nicol D, ... Hopkins MM. (2019). Continental drift? Do European clinical genetic testing laboratories have a patent problem?. European journal of human genetics : EJHG, 27(7), pp. 997-1007. doi: 10.1038/s41431-019-0368-7

Liddicoat J, de Werra J. (2019). When can exclusive licensees initiate patent infringement proceedings?—Lessons for global IP licensing transactions from two recent UK cases. Journal of Intellectual Property Law & Practice, (1), doi: 10.1093/jiplp/jpy159

Minssen T, van Zimmeren E, Wested J. (2018). Clearing a path through the CRISPR patent jungle. Life Sciences Intellectual Property Review (LSIPR), (08-05-2018),

Minssen T, Van Zimmeren E, Wested J. (2018). Opportunities and challenges for user-generated licensing models in gene-editing. http://blog.petrieflom.law.harvard.edu/,

Minssen T, Pierce J. (2018). Big Data and Intellectual Property Rights in the Health and Life Sciences. Big Data, Health Law, and Bioethics  (pp. 311-323). Cambridge University Press.

Minssen T, Bostyn S. (2018). A Ray of Light in Muddy Waters? -The CJEU rules on combination SPCs in C-121/17 Teva v Gilead. European Pharmaceutical Law Review, 2(3), pp. 169-173.

Minssen T, Schovsbo J. (2018). Big Data in the Health and Life Sciences : What Are the Challenges for European Competition Law and Where Can They Be Found?. Big Data in the Health and Life Sciences : What Are the Challenges for European Competition Law and Where Can They Be Found? Intellectual Property and Digital Trade in the Age of Artificial Intelligence and Big Data. ed. / Xavier Seuba; Christophe Geiger; Julien Pénin. Centre d'études internationales de la propriété intellectuelles (CEIPI), 2018.  (pp. 10).

Minssen T, Herrmann J R, Schovsbo J. (2019). MUCH ADO ABOUT SOMETHING: LEGAL, ETHICAL AND SCIENTIFIC CHALLENGES IN INTERNATIONAL BIOBANKING AND TRANSLATIONAL EXPLOITATION. In Minssen T, Herrmann J R, Schovsbo J. (Ed.), Global Genes, Local Concerns- Legal, Ethical and Scientific Challenges in International Biobanking  (pp. 5). Edward Elgar Publishing.

Minssen T, Rajam N, Bogers M. (2019). Clinical trials data transparency & GDPR compliance: What are the effects on data sharing and open innovation?. Science and Public Policy,

Minssen T, Mimler M, Mak V. (2019). When does stand-alone software qualify as a medical device in the European Union? (under review): The CJEU decision in SNITEM and what it implies for the next generation of medical devices. Medical Law Review,

Minssen T, Valentin A, Hajrizaj P. (2019). Denmark. In Berkowitz M, Thompson J, Norton A, Collingwood C, Williams R, Falach A. (Ed.), GLOBAL LEGAL INSIGHTS AI, BIG DATA & MACHINE LEARNING  (pp. 14). Global Legal Insights.

Minssen T, Kesselheim AS, Darrow JJ. (2019). An export-only exception to pharmaceutical patents in Europe: should the United States follow suit?. Nature biotechnology, 37(1), pp. 21-22. doi: 10.1038/nbt.4324

Minssen T, Wested J. (2019). An Update on Research- & Bolar exemptions in the U.S. and Europe: Unsolved questions and new developments in an increasingly important area of law. NIR: Nordiskt Immateriellt Rättsskydd, 2, pp. 168-183.

Minssen T, Herrmann J R, Schovsbo J. (2019). Global Genes, Local Concerns- Legal, Ethical and Scientific Challenges in International Biobanking. Edward Elgar Publishing.

Minssen T. (2018). Fair Data Sharing & Data Caring In The Digitalized Era: Aspirations, Realities & Legal Clashes In The Health & Life Sciences.

Minssen T. (2019). ELSI challenges of AI and the Medicus L(ex) Machina. Statens medicinsk-etiska råd (S 1985:A) (Sweden).

Minssen T. (2019). AI in the Health & Life Sciences & the Medicus L(ex) Machina: Setterwalls Life Sciences Report (2019). Setterwalls (Law Firm).

Mundkur ML, Franklin J, Huybrechts KF, Fischer MA, Kesselheim AS, Linder JA, ... Patorno E. (2018). Changes in Outpatient Use of Antibiotics by Adults in the United States, 2006-2015. Drug safety, 41(12), pp. 1333-1342. doi: 10.1007/s40264-018-0697-4

Neethu R, Minssen T. (2019). What lurks in the shadows of the openness hyperbole for biopharmaceuticals?. Drug development research, 80(3), pp. 282-284. doi: 10.1002/ddr.21526

Nicol D, Dreyfuss RC, Gold ER, Li W, Liddicoat J, Van Overwalle G. (2019). International Divergence in Gene Patenting. Annual review of genomics and human genetics, 20, pp. 519-541. doi: 10.1146/annurev-genom-083118-015112

Nilsson N, Minssen T. (2018). Unlocking the full potential of open innovation in the life sciences through a classification system. Drug Discovery Today, 23(4), pp. 771-775.

Nordberg A, Minssen T, de Miguel Beriain I, Wartiovaara K, Galvagni L, Feeney O. (2018). Response to Nuffield Council on Bioethics’ Genome Editing and Human Reproduction: Open Call for Evidence. Nuffield Council on Bioethics, 28 Bedford Square London WC1B 3JS: Nuffield Council on Bioethics (2018)  (London: Nuffield Council on Bioethics).

Nordberg A, Minssen T, Holm S, Horst M, Mortensen K, Møller BL. (2018). Cutting edges and weaving threads in the gene editing (Я)evolution: reconciling scientific progress with legal, ethical, and social concerns. Journal of law and the biosciences, 5(1), pp. 35-83. doi: 10.1093/jlb/lsx043

Nordberg A, Minssen T, Feeney O, de Miguel Beriain I, Galvagni L, Wartiovaara K. (2019). Editing Humanity?: An Interdisciplinary commentary on Genome Editing in Assisted Reproductive Technology. Bioethics,

Powers JH, Evans SR, Kesselheim AS. (2018). Studying new antibiotics for multidrug resistant infections: are today's patients paying for unproved future benefits?. BMJ (Clinical research ed.), 360, pp. k587. doi: 10.1136/bmj.k587

Price WN, Cohen IG. (2019). Privacy in the age of medical big data. Nature medicine, 25(1), pp. 37-43. doi: 10.1038/s41591-018-0272-7

Price WN, Gerke S, Cohen IG. (2019). Potential Liability for Physicians Using Artificial Intelligence. JAMA, doi: 10.1001/jama.2019.15064

Price WN, Kaminski ME, Minssen T, Spector-Bagdady K. (2019). Shadow health records meet new data privacy laws. Science (New York, N.Y.), 363(6426), pp. 448-450. doi: 10.1126/science.aav5133

Price WN. (2018). Big data and black-box medical algorithms. Science translational medicine, 10(471), doi: 10.1126/scitranslmed.aao5333

Rex JH, Fernandez Lynch H, Cohen IG, Darrow JJ, Outterson K. (2019). Designing development programs for non-traditional antibacterial agents. Nature communications, 10(1), pp. 3416. doi: 10.1038/s41467-019-11303-9

Rome BN, Kesselheim AS. (2019). Transferrable Market Exclusivity Extensions to Promote Antibiotic Development: An Economic Analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, doi: 10.1093/cid/ciz1039

Sherkow JS, Minssen T. (2018). ANALYSING A COMPLEX RELATIONSHIP: AIRR DATA AND THE E.U. TRADE SECRETS DIRECTIVE. Social Science Research Network (SSRN).

Vayena E, Blasimme A, Cohen IG. (2018). Machine learning in medicine: Addressing ethical challenges. PLoS medicine, 15(11), pp. e1002689. doi: 10.1371/journal.pmed.1002689

Wested J, Minssen T, Van Zimmeren E. (2018). Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach?. Bill of Health,

Wested J, Minssen T, Van Zimmeren E. (2018). Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?. Life Sciences Intellectual Property Review (LSIPR),

Yu H. (2018). The European Open Science Cloud and Commercialization. Nature Biotechnology, 36, pp. 1133–1134.

Yu, H. (2019). Leveraging Research Failures to Accelerate Drug Discovery and Development. Therapeutic Innovation & Regulatory Science,